$1 Billion is the total value of ARMISTICE CAPITAL, LLC's 67 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 70.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Sell | SPDR S&P 500 ETF TRput | $149,442,000 | +2.6% | 560,000 | -3.4% | 14.90% | -13.2% |
DEPO | Sell | DEPOMED INC | $29,447,000 | +9.3% | 3,658,000 | -21.4% | 2.94% | -7.5% |
FRPT | Sell | FRESHPET INC | $24,483,000 | +10.8% | 1,292,000 | -8.5% | 2.44% | -6.2% |
TLRDQ | Sell | TAILORED BRANDS INC | $17,027,000 | +26.5% | 780,000 | -16.3% | 1.70% | +7.1% |
SAM | Sell | BOSTON BEER INCcl a | $12,230,000 | +11.9% | 64,000 | -8.6% | 1.22% | -5.4% |
IRBT | Sell | IROBOT CORP | $9,818,000 | -3.5% | 128,000 | -3.0% | 0.98% | -18.3% |
QRTEA | Sell | LIBERTY INTERACTIVE CORP | $8,596,000 | -47.9% | 352,000 | -49.7% | 0.86% | -55.9% |
BLUE | Sell | BLUEBIRD BIO INC | $6,234,000 | +19.4% | 35,000 | -7.9% | 0.62% | +1.1% |
MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $5,507,000 | -42.3% | 60,000 | -71.7% | 0.55% | -51.1% |
ENTA | Sell | ENANTA PHARMACEUTICALS INC | $5,164,000 | +2.2% | 88,000 | -18.5% | 0.52% | -13.4% |
APRI | Sell | APRICUS BIOSCIENCES INC | $1,564,000 | -36.9% | 850,000 | -41.4% | 0.16% | -46.6% |
EYEG | Sell | EYEGATE PHARMACEUTICALS INC | $1,374,000 | -27.3% | 1,284,000 | -20.5% | 0.14% | -38.6% |
OPGN | Exit | OPGEN INC | $0 | – | -464,195 | -100.0% | -0.02% | – |
ADMS | Exit | ADAMAS PHARMACEUTICALS INCcall | $0 | – | -26,000 | -100.0% | -0.06% | – |
AVIR | Exit | AVIRAGEN THERAPEUTICS INC | $0 | – | -1,378,463 | -100.0% | -0.11% | – |
MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -132,000 | -100.0% | -0.29% | – |
EGLTQ | Exit | EGALET CORP | $0 | – | -2,050,000 | -100.0% | -0.31% | – |
TSN | Exit | TYSON FOODS INCcl a | $0 | – | -50,000 | -100.0% | -0.42% | – |
PIR | Exit | PIER 1 IMPORTS INC | $0 | – | -840,000 | -100.0% | -0.42% | – |
SFM | Exit | SPROUTS FMRS MKT INC | $0 | – | -236,000 | -100.0% | -0.52% | – |
ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -1,020,000 | -100.0% | -0.54% | – |
NTRI | Exit | NUTRI SYS INC NEW | $0 | – | -100,000 | -100.0% | -0.66% | – |
BETR | Exit | AMPLIFY SNACK BRANDS | $0 | – | -816,000 | -100.0% | -0.68% | – |
SEAS | Exit | SEAWORLD ENTMT INCcall | $0 | – | -500,000 | -100.0% | -0.76% | – |
ETSY | Exit | ETSY INC | $0 | – | -400,000 | -100.0% | -0.80% | – |
ZGNX | Exit | ZOGENIX INCput | $0 | – | -200,000 | -100.0% | -0.83% | – |
TTSH | Exit | TILE SHOP HLDGS INC | $0 | – | -632,000 | -100.0% | -0.94% | – |
FTDCQ | Exit | FTD COS INC | $0 | – | -624,000 | -100.0% | -0.96% | – |
Exit | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $0 | – | -21,760,000 | -100.0% | -1.08% | – | |
ANF | Exit | ABERCROMBIE & FITCH COcl a | $0 | – | -700,000 | -100.0% | -1.19% | – |
PII | Exit | POLARIS INDS INC | $0 | – | -100,000 | -100.0% | -1.23% | – |
COH | Exit | COACH INC | $0 | – | -260,000 | -100.0% | -1.23% | – |
TPX | Exit | TEMPUR SEALY INTL INCcall | $0 | – | -200,000 | -100.0% | -1.52% | – |
DKS | Exit | DICKS SPORTING GOODS INC | $0 | – | -500,000 | -100.0% | -1.59% | – |
SHPG | Exit | SHIRE PLCcall | $0 | – | -100,000 | -100.0% | -1.80% | – |
ADMS | Exit | ADAMAS PHARMACEUTICALS INC | $0 | – | -750,000 | -100.0% | -1.87% | – |
INCY | Exit | INCYTE CORP | $0 | – | -146,000 | -100.0% | -2.01% | – |
NOMD | Exit | NOMAD FOODS LTD | $0 | – | -1,488,000 | -100.0% | -2.55% | – |
REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -50,000 | -100.0% | -2.63% | – |
CPB | Exit | CAMPBELL SOUP COcall | $0 | – | -500,000 | -100.0% | -2.76% | – |
DECK | Exit | DECKERS OUTDOOR CORPcall | $0 | – | -500,000 | -100.0% | -4.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2018-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
INCYTE CORP | 21 | Q3 2023 | 2.8% |
VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.